Glucose availability determines silver nanoparticles toxicity in HepG2.

MLA

Zuberek, Mariusz, et al. “Glucose Availability Determines Silver Nanoparticles Toxicity in HepG2.” Journal of Nanobiotechnology, vol. 13, Oct. 2015, p. 72. EBSCOhost, https://doi.org/10.1186/s12951-015-0132-2.

APA

Zuberek, M., Wojciechowska, D., Krzyzanowski, D., Meczynska-Wielgosz, S., Kruszewski, M., & Grzelak, A. (2015). Glucose availability determines silver nanoparticles toxicity in HepG2. Journal of Nanobiotechnology, 13, 72. https://doi.org/10.1186/s12951-015-0132-2

Chicago

Zuberek, Mariusz, Dominika Wojciechowska, Damian Krzyzanowski, Sylwia Meczynska-Wielgosz, Marcin Kruszewski, and Agnieszka Grzelak. 2015. “Glucose Availability Determines Silver Nanoparticles Toxicity in HepG2.” Journal of Nanobiotechnology 13 (October): 72. doi:10.1186/s12951-015-0132-2.